Yik***ang

客户服务, 药物, 日语, 医学研究

External Cooperation and Affairs at 上海瑞宏迪医药有限公司

• Location: 中国 上海市
• Duration: 2023-06 to Present
• Description: Shanghai Regenelead Therapies Co., Ltd. is an associate company invested by Jiangsu Hengrui Pharmaceuticals Co., Ltd.,, focusing on the development of AAV gene therapy and mRNA drugs. The R&D pipeline focuses on neurology, ophthalmology and oncology. 1.External Cooperation: 1) Work closely with R&D, clinical, RA and MKT teams to identify opportunities for licensing, co-development and strategic cooperation worldwide; 2) Analyse and evaluate potential assets and promote due diligence and cooperation negotiations. 2. Brand building and government affairs: 1) Find and screen suitable external PR resources according to the needs of company's strategic development; 2) Responsible for docking with government ministries and commissions, develop government project declaration plan, enhance recognition and brand image. Alliance Management: 1) Participate in conflict resolution and internal teamwork to support daily partner interactions of drug development, production,supply, and commercialisation； 2) Assist in the preparation of investment reports and post-investment management reports, responsible for managing and coordinating public relations between the company and its shareholders, dealing with the daily affairs of relevant external potential investment and financing institutions.

Business Development Manager at ACROBiosystems

• Location: 中国 上海市
• Duration: 2021-08 to 2023-05
• Description: 1. As a FA agency, source potential partnering opportunities, design deal structure, and build business cases for both in-licensing and out-licensing. 2. Lead market research efforts such as epidemiology, treatment flow, qualitative or quantitative demand/market share, positioning, future treatment paradigms, etc., and develop market research reports to support client’s decision making. 3. Lead cross-functional transaction team to evaluate (including due diligence), negotiate, and operationalize the transactions spanning different disease areas and technologies, and the transaction types include, but are not limited to, in-licensing, out-licensing, development collaborations, mergers and acquisitions. Project experience: • Sourcing part, responsible for the sourcing and evaluation of more than 20 assets, including small molecule, antibody drugs, ADC, cell therapy and other drug types, involving tumor, autoimmune, inflammation, metabolism and other indications. • Underwriting part, responsible for the drafting and negotiation of multiple TS, involving antibody, antibiotics and co-development.

Senior Japanese BD at Clinical Service Center

• Location: 中国 上海市
• Duration: 2019-07 to 2021-08
• Description: 1.Focus on Japanese pharmaceutical companies in Japan or China to develop the business of clinical trial development or research. 2.Responsible for project evaluation, confirmation of client's requirements, proposal design and contract signing. 3.Coordinate internal resources, undertake project management work, and promote project implementation and follow up. Work closely with registration affairs, clinical operation, medical strategy and other functional departments. 4.Responsible for investigating domestic and foreign market demand for new drug research and development, information of competitors, etc., analyzing market development trend and formulating business operation strategies of the project. Project experience: • About ten Japanese pharmaceutical companies and five Chinese pharmaceutical companies have been contacted and negotiated, involving a total of more than 20 projects. • Services include drug administration consultation, medical strategy, digital systems and other separate services. Full Service projects involve BE, I, III, IV, etc. In addition, Pharma Marketing Survey, Market Support, Support interview to Experts (KOL) and other CRO services are customized according to customer needs.